Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. - Wikidata - wikimedia - TriplyDB

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.

http://www.wikidata.org/entity/Q37196234

about

M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b.The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches.P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia.αVβ3 Integrin regulates astrocyte reactivity Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression.Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis.Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice.Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulation.

P2860

Q37549540-AB044CF3-E96A-44FA-BBFE-B3E74C04275D Q41107984-4FA12525-B011-4FFD-8F7E-C0CF8663ABA6 Q41484919-B8AAB019-D7D3-49DB-A54C-120881F947F1 Q42368047-97F4DB41-14A3-4003-8E8E-76768B8E8D2C Q46294217-DF124E2C-4442-448C-B2DD-F958F346B789 Q47142356-4D0A248B-2ED9-4DEE-869D-EA1337467655 Q48161670-F2C69A91-738F-46E9-8A6F-BD98409E87F7 Q48281779-52F3A5C0-F149-4944-A8BA-4A1FD8D72640 Q50046171-870B6E82-74B0-4AD1-B214-C9BB10D3895E

P2860

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.

http://www.wikidata.org/entity/Q37196234

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Actions of the antihistaminerg ...... orate ALS disease progression.

@en

Actions of the antihistaminerg ...... orate ALS disease progression.

@nl

type

label

Actions of the antihistaminerg ...... orate ALS disease progression.

@en

Actions of the antihistaminerg ...... orate ALS disease progression.

@nl

prefLabel

Actions of the antihistaminerg ...... orate ALS disease progression.

@en

Actions of the antihistaminerg ...... orate ALS disease progression.

@nl

P1433

Q37196234-309A3009-68F0-4CD7-AC0B-E5FD3D5B95CC

P1476

Q37196234-7A8D097B-12AB-4D1B-80F8-975F8660ECB6

P2093

Q37196234-14FF1427-B3A4-4135-A961-98201B996634

Q37196234-7E5BDD00-1D8A-4841-A134-7E82585672AE

P2860

Q37196234-07058330-38E6-49B2-AFEC-BA02930C6502

Q37196234-09C8502E-4477-4260-8ED2-AE1693E9DB55

Q37196234-0B9F8B10-ACFB-42C2-8073-5864B6484D97

Q37196234-0E0585D1-930A-45EE-829C-E91F76A5522D

Q37196234-13B84167-DAB5-4922-BBE6-EC5740571DD3

Q37196234-166043BA-C77D-4F20-9BCD-02F06289F17A

Q37196234-18D263D2-ADE9-4841-A5E5-23533D1FEF81

Q37196234-2172ADBA-E647-407C-9B9A-15A5364CDDF0

Q37196234-251A5211-0F82-4472-BD9C-9F2E1B342B28

Q37196234-2B8D9FCF-4102-4DC7-97EC-B6F97DFAAAA4

P2888

Q37196234-77770E03-B614-45AD-9ED0-8E74245F6080

P304

Q37196234-517A0983-CC4C-4C66-86FF-8E1A1C011F84

P31

Q37196234-14C804A6-8E94-4978-B7BB-9E32537416D1

P356

Q37196234-08CEBA43-B7A9-4386-9E83-0421216120B2

P433

Q37196234-0E995A16-62DD-4B0F-8E42-C904A049AE9D

P478

Q37196234-AA1E41B8-2671-4FA0-B1D5-1EE70D20266F

P50

Q37196234-23CA7B2E-5194-465A-9D54-E74763D636D2

Q37196234-D01C8401-1306-4A79-A38C-CA3088688F6A

P577

Q37196234-8FDAE989-B2C4-4F12-ACDB-844294E439AD

P6179

Q37196234-D2493D43-0632-4F7C-A0B2-E38B7D78F3E6

P698

Q37196234-31E00715-210A-4418-B78E-21855D3E6494

P921

Q37196234-DF2F2553-7A75-4419-9563-5A49C6DE50B0

P932

Q37196234-2BECBFE8-123D-453D-BB6D-F5F4B0AC3D10

P356

S12974-016-0658-8

P1433

Journal of Neuroinflammation

P1476

Actions of the antihistaminerg ...... iorate ALS disease progression

@en

P2093

Savina Apolloni

http://www.w3.org/2001/XMLSchema#string

Susanna Amadio

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Why should autophagic flux be assessed?

Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach

Autophagy as a regulated pathway of cellular degradation

Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.

Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.

MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.

Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents

Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis.

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

P2888

s12974-016-0658-8

P304

191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12974-016-0658-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Cinzia Volonté

Paola Fabbrizio

P577

2016-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042193896

http://www.w3.org/2001/XMLSchema#string

P698

27549088

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4994328

http://www.w3.org/2001/XMLSchema#string